Faruk Skenderi
Faruk Skenderi is an expert in Oncology at Sarajevo School of Science and Technology (Bosnia and Herzegovina). As of October 2026, ScienceLeadR ranks Faruk Skenderi in the top 1% of experts in Bosnia and Herzegovina for Urologic Neoplasms. Faruk Skenderi has authored 66 publications, the most recent in 2026. SLR score: 147 (community average: 125). How the SLR is computed.
LeadR Profile
Oncology
Subspecialties: Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2026
Number : 66
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Paper mills in evidence synthesis: reported involvement among retracted systematic reviews and meta-analyses. PMID 42498084 — epidemiology, prevalence, research, records | J Clin Epidemiol | 2026 | 0 |
| Response to the Letter regarding "The role of reviewers in the era of systematic reviews and meta-analysis: A practical guide for researchers". PMID 41973759 — language, biomedical research, peer review | Biomol Biomed | 2026 | 0 |
| Glycogen-Rich Clear Cell Carcinoma of the Breast: Report of Two New Cases and an Updated Literature Review. PMID 41268740 — cells, glycogen, breast, therapeutics | Acta Med Acad | 2025 | 0 |
| Acinic Cell Carcinoma of the Breast: A Population-Based Clinicopathologic Study. PMID 41046342 — cells, acinar cells, breast neoplasms, neoplasms, breast, carcinoma, acinar cell | Cancer Rep (Hoboken) | 2025 | 0 |
| The role of reviewers in the era of systematic reviews and meta-analysis: A practical guide for researchers. PMID 40684471 — bias, biomedical research, work | Biomol Biomed | 2025 | 0 |
LeadR Networks
Main global connection map